News Agency
Men's Weekly

Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau

  • Written by PR Newswire
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau

The prospectively defined, double-blind analysis of biomarker-positive patients with mild Alzheimer's disease showed more rapid clinical progression in biomarker-positive patients, highlighting the suitability of elevated pTau for selecting patients in the on-going XanaMIA phase 2b trial

SYDNEY, June 26, 2024 /PRNewswire/ -- Actinogen Medical...

Read more: Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease...

3PL Companies Powering Efficient Logistics And Scalable Business Growth

Behind every smooth online order and timely delivery, there’s often an invisible engine working tirelessly in the background. That engine is powered by 3PL companies, quietly orchestrating storage, packing, and shipping so businesses can focus on what they do best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion